Globus Medical, Inc. (GMED)

Market Cap	11.38B
Revenue (ttm)	2.48B
Net Income (ttm)	91.51M
Shares Out	136.17M
EPS (ttm)	0.67
PE Ratio	124.56
Forward PE	25.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	904,406
Open	83.23
Previous Close	83.32
Day's Range	82.35 - 83.91
52-Week Range	44.02 - 84.87
Beta	1.17
Analysts	Buy
Price Target	86.15 (+3.06%)
Earnings Date	Nov 5, 2024

About GMED

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, tot...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 3, 2012
• Employees: 5,000
• Stock Exchange: NYSE
• Ticker Symbol: GMED
• Website: https://www.globusmedical.com

Financial Performance

In 2023, Globus Medical's revenue was $1.57 billion, an increase of 53.34% compared to the previous year's $1.02 billion. Earnings were $122.87 million, a decrease of -35.39%.

Analyst Forecast

According to 14 analysts, the average rating for GMED stock is "Buy." The 12-month stock price forecast is $86.15, which is an increase of 3.06% from the latest price.

Price Target

$86.15

(3.06% upside)

Analyst Consensus: Buy